background:

Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), also known as B cell maturation protein (BCMA), CD antigen CD269, is a member of the TNF receptor superfamily. TNFRSF17 contains a TNFR-Cys repeat sequence. TNFRSF17 is expressed in mature B cells, but not in T cells or monocytes. TNFRSF17 is a receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B cell survival and plays a role in humoral immune regulation. TNFRSF17 can activate NF-kappa-B and JNK.

Overview:

Antigen name : Human BCMA / TNFRSF17 Protein, His Tag;

Other names : TNFRSF17, CD269, BCM, BCMA;

Sequence source : Human BCMA, high-quality (BCA-H522y) expressed by human 293 cells (HEK293), with His tag;

Molecular Weight : The calculated molecular weight of this protein is 7.8 kDa. Due to glycosylation, the protein migrates at 12 kDa and 14-18 kDa under reducing conditions (SDS-PAGE).

Packaging specifications:
Rhinogen® recombinant human BCMA/TNFRSF17 protein (His tag) packaging specifications are as follows ^:

Storage temperature:

This product can be stored in a freeze-dried state at -20°C to -70°C for 12 months; after reconstitution, it can be stored at -70°C under sterile conditions for 3 months. Please avoid repeated freezing and thawing.

Characteristics:
Purity: Purity in SDS-PAGE reduction electrophoresis>90%.